Displaying drugs 4451 - 4475 of 11848 in total
Camellia japonica seed oil
Camellia japonica seed oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Experimental
Matched Description: … Camellia japonica seed oil is a plant/plant extract used in some OTC (over-the-counter) products. …
Presatovir
Presatovir has been used in trials studying the treatment of RSV Infection, Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus Infections, and Respiratory Syncytial Virus (RSV) Infections.
Investigational
Matched Iupac: … N-{2-[(2S)-2-{5-[(3S)-3-aminopyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl}piperidine-1-carbonyl …
PIKA rabies vaccine
PIKA rabies vaccine is a novel vaccine developed by YS Biopharma.
Investigational
Matched Description: … PIKA rabies vaccine is a novel vaccine developed by YS Biopharma. …
Cefminox
Cefminox (INN) is a second generation cephalosporin antibiotic. It is approved for use in Japan.
Experimental
Matched Description: … Cefminox (INN) is a second generation cephalosporin antibiotic. It is approved for use in Japan. …
Corticorelin acetate
Corticorelin acetate has been investigated for the treatment of Brain Edema and Brain Tumor.
Investigational
AG0301-COVID19
AG0301-COVID19 is a vaccine candidate developed by AnGes Inc. and Osaka University. The candidate is a plasmid DNA vaccine developed using an intradermal gene transfer method targeting the SARS-CoV-2 spike protein. The gene transfer method increases the efficiency of gene expression and antibody production capability, garnering a more efficient DNA...
Investigational
Matched Description: … AG0301-COVID19 is a vaccine candidate developed by AnGes Inc. and Osaka University. ... The candidate is a plasmid DNA vaccine developed using an intradermal gene transfer method targeting ... transfer method increases the efficiency of gene expression and antibody production capability, garnering a …
AG0302-COVID19
Sponsored by Anges, Inc. in Japan, the AG0302-COVID19 is a DNA-based vaccine that recently completed Phase I/II trials (NCT04527081)[A226813, L30548].
Investigational
Matched Description: … Sponsored by Anges, Inc. in Japan, the AG0302-COVID19 is a DNA-based vaccine that recently completed …
Autologous cord blood
Investigational
Phenacetin
Phenacetin was withdrawn from the Canadian market in June 1973 due to concerns regarding nephropathy (damage to or disease of the kidney).
Withdrawn
2-Aminophenol
Experimental
M-Cresol
Experimental
Duroquinone
Experimental
Coelenteramide
Experimental
2-Amino-4-methylphenol
Experimental
MM-111
MM-111 is a novel bispecific antibody fusion protein that co-targets the the epidermal growth factor family receptor tyrosine kinases, ERBB2 and ERBB3.
Investigational
Matched Description: … MM-111 is a novel bispecific antibody fusion protein that co-targets the the epidermal growth factor …
Sucrosofate
Experimental
Hopantenic acid
Hopantenic acid (Pantogam) is a central nervous system depressant. Hopantenic acid has a unique spectrum of pharmacological effects (nootropic, anticonvulsant, mild activating) in the absence of addiction, hyperstimulation or withdrawal syndrome.
Experimental
Matched Description: … Hopantenic acid (Pantogam) is a central nervous system depressant. ... Hopantenic acid has a unique spectrum of pharmacological effects (nootropic, anticonvulsant, mild activating …
Phellodendron amurense bark
Phellodendron amurense bark is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Experimental
Matched Description: … Phellodendron amurense bark is a plant/plant extract used in some OTC (over-the-counter) products. …
Cetilistat
Cetilistat is a novel inhibitor of pancreatic lipase being developed by Alizyme for the treatment of obesity and associated co-morbidities, including type 2 diabetes.
Investigational
Matched Description: … obesity and associated co-morbidities, including type 2 diabetes. ... Cetilistat is a novel inhibitor of pancreatic lipase being developed by Alizyme for the treatment of …
GI heptapeptide
GI heptapeptide is under investigation in clinical trial NCT01391208 (Esophageal Protocol for Detection of Neoplasia in the Digestive Tract).
Investigational
Resveratrol
Resveratrol (3,5,4'-trihydroxystilbene) is a polyphenolic phytoalexin. It is a stilbenoid, a derivate of stilbene, and is produced in plants with the help of the enzyme stilbene synthase. It exists as cis-(Z) and trans-(E) isomers. The trans- form can undergo isomerisation to the cis- form when heated or exposed to ultraviolet...
Investigational
Matched Description: … In a 2004 issue of Science, Dr. ... It is a stilbenoid, a derivate of stilbene, and is produced in plants with the help of the enzyme stilbene ... Resveratrol (3,5,4'-trihydroxystilbene) is a polyphenolic phytoalexin. …
Matched Mixtures name: … Co-Balamin ... Co-Veratrol …
Matched Categories: … Compounds used in a research, industrial, or household setting …
Matched Mixtures name: … Co-Balamin ... Co-Veratrol …
Matched Categories: … Compounds used in a research, industrial, or household setting …
Beraprost
Beraprost is a synthetic analogue of prostacyclin, under clinical trials for the treatment of pulmonary hypertension. It is also being studied for use in avoiding reperfusion injury.
Investigational
Matched Description: … Beraprost is a synthetic analogue of prostacyclin, under clinical trials for the treatment of pulmonary …
Trapidil
Trapidil, a platelet-derived growth factor antagonist, was originally developed as a vasodilator and anti-platelet agent and has been used to treat patients with ischemic coronary heart, liver, and kidney disease.
Experimental
Matched Iupac: … N,N-diethyl-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine …
Matched Description: … Trapidil, a platelet-derived growth factor antagonist, was originally developed as a vasodilator and …
Matched Description: … Trapidil, a platelet-derived growth factor antagonist, was originally developed as a vasodilator and …
Arimoclomol
Arimoclomol is an experimental drug compound developed by CytRx Corporation, a biopharmaceutical company based in Los Angeles, California. The orally administered drug is intended to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, a neurodegenerative disease with no effective treatment.
Investigational
Matched Description: … Arimoclomol is an experimental drug compound developed by CytRx Corporation, a biopharmaceutical company ... drug is intended to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, a …
Displaying drugs 4451 - 4475 of 11848 in total